hotspot -WSS

hotspot

author：comprehensive 2025-09-29 21:14:52 - browse：97

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： PBM reform efforts get punted in Congress

focus

Wikipedia

WSS

He's 19 months old and has one of the world’s rarest diseases

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Ancient Greek ideas underpin modern concepts of pregnancy

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

In utero gene editing: an explainer

Longer MASH drug regimen improved liver, Akero study finds

focus

hotspot

hotspot

At least 13 dead in Texas as scorching temps continue

He's 19 months old and has one of the world’s rarest diseases

Sports medicine is finally prioritizing gender equality

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Psychedelics group wrestles with new pharma identity

He's a Nobel laureate. Critics say he was misleading on Covid

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Cancer drug shortages should be causing more outrage

Why palliative psychiatry is worth discussing

focus

Ozempic has benefits for kidney disease as well as diabetes

6 phony surgeries that take placebo to the extreme

Stem cell biologist probes earliest stages of human development

A new approach to psychiatric drug development

$1 billion proposal to grow Boston, Massachusetts biotech

Readout Newsletter: BridgeBio, Akero, and human embryo models

Wikipedia

focus

Wikipedia

hotspot